HR 2343 · 119th CongressIn Committeecongress.gov ↗
What this bill does
AI plain-language summaryThis bill would allow Medicare to cover a specific treatment for people who have a protein deficiency called alpha-1 antitrypsin deficiency that has caused them to develop emphysema. The treatment, called augmentation therapy, could be given at home through qualified suppliers. Patients would need to be under the care of a doctor, nurse practitioner, or physician assistant to receive this coverage.
Your Vote
Discussion (0)
Explain what is at stake in this bill.
Sign in to join the discussion.
No comments yet. Be the first.